1-3 of 3
Claire Hidalgo-Curtis, PhD
Close
Sort by
Journal Articles

Inactivation of Polycomb Repressive Complex 2 Components in Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms

Nicholas C.P. Cross, PhD, FRCPath, Joannah Score, PhD, Claire Hidalgo-Curtis, PhD, Amy V Jones, PhD, Nils Winkelmann, MD, Alison Skinner, BSc, Daniel Ward, MSc, Katerina Zoi, MD, PhD, Thomas Ernst, MD, Frank Stegelmann, MD, Konstanze Dohner, MD, PhD, Andrew J Chase, PhD
Journal: Blood
Blood (2011) 118 (21): 617.
https://doi.org/10.1182/blood.V118.21.617.617
Published: 2011
Journal Articles

Prognostic Impact of EZH2 and ASXL1 Mutation in Myelofibrosis

Paola Guglielmelli, MD, PhD, Flavia Biamonte, BiSc, Johannah Score, Claire Hidalgo-Curtis, PhD, Francisco Cervantes, MD, PhD, Margherita Maffioli, MD, Tiziana Fanelli, BiSci, Thomas Ernst, MD, Nils Winkelman, MD, Amy V Jones, PhD, Katerina Zoi, MD, PhD, Andreas Reiter, MD, Andrew Duncombe, MD, Laura Villani, Biol Sci, Chiara Paoli, BiSci, Alberto Bosi, MD, Giovanni Barosi, MD, Nicholas C.P. Cross, PhD, Alessandro M. Vannucchi, MD
Journal: Blood
Blood (2011) 118 (21): 2811.
https://doi.org/10.1182/blood.V118.21.2811.2811
Published: 2011
Journal Articles

Frequent Inactivating Mutations of TET2 and CBL Are Associated with Acquired Uniparental Disomy in Atypical Chronic Myeloid Leukemia and Related Disorders.

Thomas Ernst, MD, Andrew Chase, PhD, Claire Hidalgo-Curtis, PhD, Katerina Zoi, PhD, Christine Zoi, MD, Andreas Hochhaus, MD, Andreas Reiter, MD, William Vainchenker, MD, PhD, Francis Grand, PhD, Nicholas C.P. Cross, PhD
Journal: Blood
Blood (2009) 114 (22): 3258.
https://doi.org/10.1182/blood.V114.22.3258.3258
Published: 2009